SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-023382
Filing Date
2024-02-05
Accepted
2024-02-05 06:09:28
Documents
2
Group Members
FREDERICK V. FORTMILLER, JR.HARRADEN CIRCLE INVESTORS GP, LLCHARRADEN CIRCLE INVESTORS GP, LPHARRADEN CIRCLE INVESTORS, LPHARRADEN CIRCLE SPECIAL OPPORTUNITIES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G d764900dsc13g.htm SC 13G 108245
2 EX-99.1 d764900dex991.htm EX-99.1 6838
  Complete submission text file 0001193125-24-023382.txt   116955
Mailing Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171
Business Address 299 PARK AVE 21ST FLOOR NEW YORK NY 10171 212 832 4111
Harraden Circle Investments, LLC (Filed by) CIK: 0001910592 (see all company filings)

IRS No.: 813057945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Subject) CIK: 0001985062 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94325 | Film No.: 24593852
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)